Table 1

Baseline Patient Characteristics

CharacteristicExperimental (n = 104)Control (n = 102)P Value
Age, mean (SD), y64.2 (9.0)64.6 (8.4).73
Male, No. (%)
Working status, No. (%)		61 (58.7)58 (56.9).79
.62
    Full-time34 (32.7)28 (27.5)
    Part-time10 (9.6)13 (12.7)
    Not working60 (57.7)61 (59.8)
Type of lung cancer, No. (%).32
    Squamous cell carcinoma14 (13.5)22 (21.6)
    Adenomatous carcinoma53 (51.0)47 (46.1)
    Small cell carcinoma24 (23.1)23 (22.5)
    Other non-small cell carcinoma13 (12.5)10 (9.8)
Treatment, No. (%).74
    Chemotherapy36 (34.6)43 (42.2)
    Radiation5 (4.8)4 (3.9)
    Chemotherapy and radiation57 (54.8)50 (49.0)
    No treatment6 (5.8)5 (4.9)
Metastasis, No. (%)49 (47.1)53 (52.0).58
TNM classification, No. (%).57
    Stage 1 and 27 (6.7)3 (2.9)
    Stage 334 (32.7)30 (29.4)
    Stage 436 (34.6)43 (42.2)
    Unclassifieda27 (26.0)26 (25.5)
Functional status, No. (%)b.11
    Active56 (53.8)41 (40.2)
    Ambulatory but bothered by symptoms33 (31.7)36 (35.3)
    <50% bedridden11 (10.6)12 (11.8)
    ≥50% bedridden4 (3.8)12 (11.8)
    Always bedridden0 (0)1 (1.0)

  • TNM = TNM Classification of Malignant Tumors.

  • ↵aMost patients had small cell carcinoma, for which there is no TNM classification.

  • ↵bFunctional status according to Eastern Collaborative Oncology Group scale.